Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
Nature (London), 2022-03, Vol.603 (7903), p.942-948 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Mar 31, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04508-4 ;PMID: 35322232
Full text available